Cotton wool spots associated with interferon beta-1 alpha therapy

Seminars in Ophthalmology

Volumn 22, Issue 1, 2007, Pages 49-53

  Longmuir, Reid ^a   Lee, Andrew G ^a,b   Rouleau, Jacinthe ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b Department of Ophthalmology   (United States)

Author keywords

Cotton wool patch; Interferon beta1 a; Multiple sclerosis

Indexed keywords

ACETYLSALICYLIC ACID; AMANTADINE; BETA1A INTERFERON; BUTALBITAL; CITALOPRAM; GABAPENTIN; GLATIRAMER; METAXALONE; PARACETAMOL; ROFECOXIB; TRAZODONE; VERAPAMIL; ZOLPIDEM;

ADULT; ARTICLE; CASE REPORT; COTTON WOOL SPOT; EYE FUNDUS; HUMAN; MALE; MULTIPLE SCLEROSIS; MYELITIS; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA DISEASE; RETINOPATHY; SLIT LAMP; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ADULT; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNDUS OCULI; HUMANS; INTERFERON-BETA; MALE; MULTIPLE SCLEROSIS; RETINAL DISEASES;

EID: 33847656153     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.1080/08820530601182725     Document Type: Article

References (16)

1. Guyer DR, Tiedeman J, Yannuzzi LA, et al. Interferon-associated retinopathy. Arch Ophthalmol 1993; 111:350-6.
2. Hayasaka S, Fujii M, Yamamoto Y, Noda S, Kurome H, Sasaki M. Retinopathy and subconjunctival haemorrhage in patients with chronic viral hepatitis receiving interferon alfa. Br J Ophthalmol 1995; 79:150-2.
3. Hayasaka S, Nagaki Y, Matsumoto M, Sato S. Interferon associated retinopathy. Br J Ophthalmol 1998; 82:323-5.
4. Hejny C, Sternberg P, Lawson DH, Greiner K, Aaberg TM, Jr. Retinopathy associated with high-dose interferon alfa-2b therapy. Am J Ophthalmol 2001; 131:782-7.
5. Kadayifcilar S, Boyacioglu S, Kart H, Gursoy M, Aydin P. Ocular complications with high-dose interferon alpha in chronic active hepatitis. Eye 1999; 13( Pt 2):241-6.
6. Schulman JA, Liang C, Kooragayala LM, King J. Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin. Ophthalmology 2003; 110:437-42.
7. Cuthbertson FM, Davies M, McKibbin M. Is screening for interferon retinopathy in hepatitis C justified? Br J Ophthalmol 2004; 88:1518-20.
8. Purvin VA. Anterior ischemic optic neuropathy secondary to interferon alfa. Arch Ophthalmol 1995; 113:1041-4.
9. Sugano S, Yanagimoto M, Suzuki T, et al. Retinal complications with elevated circulating plasma C5a associated with interferon-alpha therapy for chronic active hepatitis C. Am J Gastroenterol 1994; 89:2054-6.
10. Okuse C, Yotsuyanagi H, Nagase Y, et al. Risk factors for retinopathy associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis C. World J Gastroenterol 2006; 12:3756-9.
11. Sommer S, Sablon JC, Zaoui M, Rozot P, Hosni A. Interferon beta-1b retinopathy during a treatment for multiple sclerosis. J Fr Ophtalmol 2001; 24:509-12.
12. Mallada-Frechin J, Abellan-Miralles I, Alfaro-Beltra ML, et al. Retinopathy secondary to treatment with Interferon beta-1a in a patient with multiple sclerosis. Rev Neurol 2005; 40:482-4.
13. Baron S, Tyring SK, Fleischmann WR, Jr., et al. The interferons. Mechanisms of action and clinical applications. JAMA 1991; 266:1375-83.
14. Taniguchi T, Mantei N, Schwarzstein M, Nagata S, Muramatsu M, Weissmann C. Human leukocyte and fibroblast interferons are structurally related. Nature 1980; 285:547-9.
15. Novick D, Cohen B, Rubinstein M. The human interferon alpha/beta receptor: characterization and molecular cloning. Cell 1994; 77:391-400.
16. Neilley LK, Goodin DS, Goodkin DE, Hauser SL. Side effect profile of interferon beta-1b in MS: results of an open label trial. Neurology 1996; 46:552-4.